MBD2 Rekombinanter Antikörper
MBD2 Rekombinant Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
250339G9
Kat-Nr. : 86393-3-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
86393-3-PBS bindet in WB, Indirect ELISA MBD2 und zeigt Reaktivität mit human, Maus
| Getestete Reaktivität | human, Maus |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | Peptid |
| Vollständiger Name | methyl-CpG binding domain protein 2 |
| Berechnetes Molekulargewicht | 43 kDa |
| Beobachtetes Molekulargewicht | 43-50 kDa |
| GenBank-Zugangsnummer | NM_003927 |
| Gene symbol | MBD2 |
| Gene ID (NCBI) | 8932 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
MBD2, also named as DMTase, binds CpG islands in promoters where the DNA is methylated at position 5 of cytosine within CpG dinucleotides. MBD2 binds hemi-methylated DNA as well. It recruits histone deacetylases and DNA methyltransferases. MBD2 acts as transcriptional repressor and plays a role in gene silencing (PMID:9774669). MBD2 belongs to a highly conserved member of the MBD protein family, is considered a reader of DNA methylation and drives the crosstalk between DNA methylation and histone deacetylation (PMID: 40089655). MBD2 drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition (PMID: 38556549).

